PLEVOVÁ, Karla, Jitka MALČÍKOVÁ, Šárka PAVLOVÁ, Jana KOTAŠKOVÁ, Lucie POPPOVÁ, Jana ŠMARDOVÁ, Eva DIVÍŠKOVÁ, Kristina ĎURECHOVÁ, Alexandra OLTOVÁ, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, Michael DOUBEK and Šárka POSPÍŠILOVÁ. Biallelic TP53 gene mutations due to copy-neutral loss of heterozygosity and monoallelic mutations in absence of 17p deletion occur in CLL with comparable frequency. In 22nd EHA Annual Congress; Madrid, Spain, červen 2017 in Haematologica (2017). 2017.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Biallelic TP53 gene mutations due to copy-neutral loss of heterozygosity and monoallelic mutations in absence of 17p deletion occur in CLL with comparable frequency
Authors PLEVOVÁ, Karla (203 Czech Republic, belonging to the institution), Jitka MALČÍKOVÁ (203 Czech Republic, belonging to the institution), Šárka PAVLOVÁ (203 Czech Republic, belonging to the institution), Jana KOTAŠKOVÁ (203 Czech Republic, belonging to the institution), Lucie POPPOVÁ (203 Czech Republic, belonging to the institution), Jana ŠMARDOVÁ (203 Czech Republic), Eva DIVÍŠKOVÁ (203 Czech Republic), Kristina ĎURECHOVÁ (203 Czech Republic), Alexandra OLTOVÁ (203 Czech Republic), Yvona BRYCHTOVÁ (203 Czech Republic), Anna PANOVSKÁ (203 Czech Republic), Michael DOUBEK (203 Czech Republic, belonging to the institution) and Šárka POSPÍŠILOVÁ (203 Czech Republic, belonging to the institution).
Edition 22nd EHA Annual Congress; Madrid, Spain, červen 2017 in Haematologica (2017), 2017.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 10606 Microbiology
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14740/17:00099490
Organization unit Central European Institute of Technology
UT WoS 000404127001134
Keywords in English TP53; heterozygosity; mutations
Tags MEDGENET, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 17/5/2018 14:12.
Abstract
Biallelic TP53 gene mutations due to copy-neutral loss of heterozygosity and monoallelic mutations in absence of 17p deletion occur in CLL with comparable frequency, Biallelic TP53 gene mutations due to copy-neutral loss of heterozygosity and monoallelic mutations in absence of 17p deletion occur in CLL with comparable frequency
Links
LQ1601, research and development projectName: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
NV15-29793A, research and development projectName: Analýza Wnt/PCP jako nástroj pro lepší management chronické lymfocytární leukémie
NV15-30015A, research and development projectName: Analýza klonální heterogenity chronické lymfocytární leukemie pomoci sekvenování nové generace genu pro B-buněčný receptor. Národní studie.
NV15-31834A, research and development projectName: Vliv selekce genomických poškození na průběh chronické lymfocytární leukémie
692298, interní kód MUName: MEDGENET - Medical genomics and epigenomics network (Acronym: MEDGENET)
Investor: European Union, Spreading excellence and widening participation
PrintDisplayed: 23/7/2024 09:27